Table 1.
Characteristics | Patients (N = 24) | Percent |
---|---|---|
No. | (%) | |
Age, years | ||
Median | 60 | |
Range | 27–75 | |
Sex | ||
Male | 2 | 8 |
Female | 22 | 92 |
SWOG performance status | ||
0 | 1 | 4 |
1 | 18 | 75 |
2 | 5 | 20 |
Histology | ||
Leiomyosarcoma | 24 | 100 |
Primary site | ||
Uterus | 11 | 46 |
Retroperitoneum | 3 | 13 |
Other | 10 | 42 |
Sites of metastases | ||
Lung | 15 | 63 |
Liver | 14 | 58 |
Other | 8 | 33 |
Prior treatment | ||
Surgery | 14 | 58 |
Radiotherapy | 3 | 13 |
Chemotherapy | 20 | 83 |
Doxorubicin | 15 | 67 |
Dacarbazine | 4 | 17 |
No. of prior chemo regimens | ||
0 | 4 | 17 |
1 | 6 | 25 |
2 | 9 | 38 |
3 | 5 | 21 |